Subjects: Cost-Benefit Analysis and Cystic Fibrosis Transmembrane Conductance Regulator -- therapeutic use / Publication Year: 2018 - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Cost-Benefit Analysis ✖ Subjects Cystic Fibrosis Transmembrane Conductance Regulator -- therapeutic use ✖ Publication Year 2018 ✖

1. Modulator treatments for cystic fibrosis: effectiveness and value : final evidence report and meeting summary

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 7, 2018
Subject(s):: Cystic Fibrosis -- drug therapy
Cystic Fibrosis Transmembrane Conductance Regulator -- therapeutic use
Clinical Trials as Topic
Cost of Illness
Cost-Benefit Analysis
Cystic Fibrosis Transmembrane Conductance Regulator -- adverse effects
Treatment Outcome
Humans
United States